MD FRCP FRCOphth FHEA DCH DRCOG DO
- Tutor and Senior Research Fellow, Harris Manchester College
Prof. Peter Scanlon has been Clinical Director for the English NHS Diabetic Eye Screening Programme since 2003, and he has, with the support and co-operation of colleagues, moved screening from limited ad hoc delivery of services to systematic quality assured processes for screening, assessment and treatment across all of England to 2.3 million people with diabetes. Dr Scanlon also holds an appointment as a Senior Research Fellow and Medical Tutor at Harris Manchester College, University of Oxford, and as Visiting Professor at the University of Gloucestershire. Dr Scanlon is Lead Author of the textbook ‘Practical Manual of Diabetic Retinopathy Management’ and has written the Diabetic Retinopathy Chapter for the Textbook of Diabetes, 4th Edition (both Wiley Blackwell).
His research interests lie in the Screening, Epidemiology, Assessment and Treatment of Diabetic Retinopathy and he has published extensively in these areas.
Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.
Scanlon PH. et al, (2016), Diabet Med, 33, 1655 - 1658
The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.
Oke JL. et al, (2016), Diabet Med, 33, 896 - 903
Screening attendance, age group and diabetic retinopathy level at first screen.
Scanlon PH. et al, (2016), Diabet Med, 33, 904 - 911
Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.
Scanlon PH. et al, (2015), Health Technol Assess, 19, 1 - 116
The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.
Scanlon PH. et al, (2015), Diabet Med, 32, 97 - 101